Search by Drug Name or NDC
NDC 42292-0040-20 Levothyroxine Sodium 175 ug/1 Details
Levothyroxine Sodium 175 ug/1
Levothyroxine Sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is LEVOTHYROXINE SODIUM.
MedlinePlus Drug Summary
Levothyroxine is used to treat hypothyroidism (condition where the thyroid gland does not produce enough thyroid hormone). It is also used with surgery and radioactive iodine therapy to treat thyroid cancer. Levothyroxine is in a class of medications called hormones. It works by replacing thyroid hormone that is normally produced by the body. Without thyroid hormone, your body cannot function properly, which may result in poor growth, slow speech, lack of energy, excessive tiredness, constipation, weight gain, hair loss, dry, thick skin, increased sensitivity to cold, joint and muscle pain, heavy or irregular menstrual periods, and depression. When taken correctly, levothyroxine reverses these symptoms.
Related Packages: 42292-0040-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Levothyroxine
Product Information
| NDC | 42292-0040 |
|---|---|
| Product ID | 42292-040_f4348cfd-4241-bfd4-e053-2995a90ab7ad |
| Associated GPIs | 28100010100335 |
| GCN Sequence Number | 006655 |
| GCN Sequence Number Description | levothyroxine sodium TABLET 175 MCG ORAL |
| HIC3 | P3A |
| HIC3 Description | THYROID HORMONES |
| GCN | 26328 |
| HICL Sequence Number | 002849 |
| HICL Sequence Number Description | LEVOTHYROXINE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Levothyroxine Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | levothyroxine sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 175 |
| Active Ingredient Units | ug/1 |
| Substance Name | LEVOTHYROXINE SODIUM |
| Labeler Name | Mylan Institutional Inc. |
| Pharmaceutical Class | Thyroxine [CS], l-Thyroxine [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076187 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42292-0040-20 (42292004020)
| NDC Package Code | 42292-040-20 |
|---|---|
| Billing NDC | 42292004020 |
| Package | 100 BLISTER PACK in 1 CARTON (42292-040-20) / 1 TABLET in 1 BLISTER PACK (42292-040-01) |
| Marketing Start Date | 2017-01-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.11223 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | LEVOTHYROXINE 175 MCG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |